Truncated hepatitis C virus NS5 domain and fusion proteins comprising same
Details for Australian Patent Application No. 2005245909 (hide)
International Classifications
Event Publications
7 December 2006 PCT application entered the National Phase
PCT publication WO2005/113837 Priority application(s): WO2005/113837
20 November 2008 Alteration of Name
The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.
27 May 2010 Application Accepted
Published as AU-B-2005245909
23 September 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005245910-C1q family member proteins with altered immunogenicity
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser